Historical record - last NADAC publication: 1/1/2024
Product Information
SUTENT 12.5 MG CAPSULE is a brand product labeled by Pfizer Inc., priced at $222.4063 per EA under NDC 00069055038. Its NADAC has been published 579 times since Dec 18, 2013.
Strength
12.5 mg/1
Manufacturer
Pfizer Inc.NDC
00069055038
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
1/1/2024
Active Ingredients
SUNITINIB MALATEApproval Type
New Drug (NDA)
FDA Application
NDA021938On Market Since
1/26/2006
Pharmacological Classes
Price Statistics
The NADAC for SUTENT 12.5 MG CAPSULE has been published 579 times since Dec 18, 2013, and over the history we have for it it has risen 110.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $222.4063 per EA |
|---|---|
| All-time high | $222.4063 (Jan 15, 2025) |
| All-time low | $105.5268 (Dec 18, 2013) |
| Median price | $176.8029 |
| Average price | $174.1365 |
| Largest weekly change | +7.0% (Jun 11, 2014) |
| Weeks tracked | 579 |
| Tracking since | Dec 18, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Sunitinib malate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of SUTENT 12.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for SUTENT 12.5 MG CAPSULE, manufactured by Pfizer Inc., is $222.4063 per EA (NDC 00069055038), effective Jan 15, 2025.
How has the price of SUTENT 12.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for SUTENT 12.5 MG CAPSULE has risen 110.8%. It has been tracked across 579 weekly CMS publications since Dec 18, 2013.
What are the highest and lowest recorded NADAC prices for SUTENT 12.5 MG CAPSULE?
Since Dec 18, 2013, the NADAC for SUTENT 12.5 MG CAPSULE has ranged from a low of $105.5268 (Dec 18, 2013) to a high of $222.4063 (Jan 15, 2025), with a median of $176.8029 per EA.
Are there cheaper alternatives to SUTENT 12.5 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of SUTENT 12.5 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures SUTENT 12.5 MG CAPSULE?
SUTENT 12.5 MG CAPSULE (NDC 00069055038) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification